Innate immunity in the central nervous system.

Immune responses in the CNS are common, despite its perception as a site of immune privilege. These responses can be mediated by resident microglia and astrocytes, which are innate immune cells without direct counterparts in the periphery. Furthermore, CNS immune reactions often take place in virtual isolation from the innate/adaptive immune interplay that characterizes peripheral immunity. However, microglia and astrocytes also engage in significant cross-talk with CNS-infiltrating T cells and other components of the innate immune system. Here we review the cellular and molecular basis of innate immunity in the CNS and discuss what is known about how outcomes of these interactions can lead to resolution of infection, neurodegeneration, or neural repair depending on the context.

[1]  R. Ransohoff,et al.  Heterogeneity of CNS myeloid cells and their roles in neurodegeneration , 2011, Nature Neuroscience.

[2]  J. McClure,et al.  Functional Duality of Astrocytes in Myelination , 2011, The Journal of Neuroscience.

[3]  R. Bainton,et al.  Physiologic and anatomic characterization of the brain surface glia barrier of Drosophila , 2011, Glia.

[4]  F. Rossi,et al.  Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool , 2011, Nature Neuroscience.

[5]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[6]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[7]  F. Safavi,et al.  Kit (W-sh) Mice Develop Earlier and More Severe Experimental Autoimmune Encephalomyelitis Due to Absence of Immune Suppression , 2011, The Journal of Immunology.

[8]  A. Waisman,et al.  Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. , 2011, Immunity.

[9]  B. Becher,et al.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation , 2011, Nature Immunology.

[10]  James J. Campbell,et al.  Epicutaneous challenge of orally immunized mice redirects antigen-specific gut-homing T cells to the skin. , 2011, The Journal of clinical investigation.

[11]  S. Masters,et al.  Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. , 2011, Trends in molecular medicine.

[12]  C. Gabay,et al.  Interleukin-33 biology with potential insights into human diseases , 2011, Nature Reviews Rheumatology.

[13]  N. Miyasaka,et al.  Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis , 2011, Annals of the rheumatic diseases.

[14]  H. Kettenmann,et al.  Physiology of microglia. , 2011, Physiological reviews.

[15]  B. Becher,et al.  CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system , 2011, Acta Neuropathologica.

[16]  M. E. Walker,et al.  Cutting Edge: Mast Cells Regulate Disease Severity in a Relapsing–Remitting Model of Multiple Sclerosis , 2011, The Journal of Immunology.

[17]  M. Colombo,et al.  Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice , 2011, Laboratory Investigation.

[18]  P. Sansonetti,et al.  NLR functions beyond pathogen recognition , 2011, Nature Immunology.

[19]  P. Magistretti,et al.  Astrocyte–neuron metabolic relationships: for better and for worse , 2011, Trends in Neurosciences.

[20]  David W. Holman,et al.  The blood-brain barrier, chemokines and multiple sclerosis. , 2011, Biochimica et biophysica acta.

[21]  J. Grutzendler,et al.  CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis , 2010, The Journal of Neuroscience.

[22]  N. Borregaard,et al.  Neutrophils, from marrow to microbes. , 2010, Immunity.

[23]  D. Attwell,et al.  Glial and neuronal control of brain blood flow , 2010, Nature.

[24]  K. Nave Myelination and support of axonal integrity by glia , 2010, Nature.

[25]  R. Ransohoff,et al.  The myeloid cells of the central nervous system parenchyma , 2010, Nature.

[26]  Ben A. Barres,et al.  Regulation of synaptic connectivity by glia , 2010, Nature.

[27]  Kerri M. Smith Neuroscience: Settling the great glia debate , 2010, Nature.

[28]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[29]  R. Ransohoff,et al.  CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. , 2010, The American journal of pathology.

[30]  T. Abe,et al.  IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.

[31]  R. Ransohoff,et al.  Regulation of Tau Pathology by the Microglial Fractalkine Receptor , 2010, Neuron.

[32]  P. Crack,et al.  Neural injury following stroke: are Toll‐like receptors the link between the immune system and the CNS? , 2010, British journal of pharmacology.

[33]  S. Chensue,et al.  EAE mediated by a non‐IFN‐γ/non‐IL‐17 pathway , 2010, European journal of immunology.

[34]  Denis Gris,et al.  NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses , 2010, The Journal of Immunology.

[35]  R. Ransohoff,et al.  Myelin Repair Is Accelerated by Inactivating CXCR2 on Nonhematopoietic Cells , 2010, The Journal of Neuroscience.

[36]  M. Tsai,et al.  Mast cells in allergy and infection: Versatile effector and regulatory cells in innate and adaptive immunity , 2010, European journal of immunology.

[37]  Martine M. Mirrione,et al.  Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice , 2010, Neurobiology of Disease.

[38]  M. E. Walker,et al.  Meningeal Mast Cells Affect Early T Cell Central Nervous System Infiltration and Blood-Brain Barrier Integrity through TNF: A Role for Neutrophil Recruitment? , 2010, The Journal of Immunology.

[39]  Anirban Basu,et al.  Inflammasome signaling at the heart of central nervous system pathology , 2010, Journal of neuroscience research.

[40]  H. Pfister,et al.  New understandings on the pathophysiology of bacterial meningitis , 2010, Current opinion in infectious diseases.

[41]  S. Abraham,et al.  Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.

[42]  D. Hume,et al.  Unravelling mononuclear phagocyte heterogeneity , 2010, Nature Reviews Immunology.

[43]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[44]  G. Graham,et al.  Astrocytes modulate the chemokine network in a pathogen-specific manner. , 2010, Biochemical and biophysical research communications.

[45]  Richard M. Page,et al.  Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease , 2010, Nature Neuroscience.

[46]  T. Möller,et al.  Microglia in ischemic brain injury. , 2010, Future neurology.

[47]  M. Karjalainen‐Lindsberg,et al.  Mast Cells as Early Responders in the Regulation of Acute Blood–Brain Barrier Changes after Cerebral Ischemia and Hemorrhage , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  R. Fairchild,et al.  Role of TNFα in Early Chemokine Production and Leukocyte Infiltration into Heart Allografts , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[49]  W. Junger,et al.  Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.

[50]  C. Glass,et al.  The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity , 2009, The Journal of Experimental Medicine.

[51]  D. Golenbock,et al.  Inflammasomes: too big to miss. , 2009, The Journal of clinical investigation.

[52]  O. Kirmi,et al.  Anatomy and imaging of the normal meninges. , 2009, Seminars in ultrasound, CT, and MR.

[53]  O. Kirmi,et al.  Imaging of the meninges and the extra-axial spaces. , 2009, Seminars in ultrasound, CT, and MR.

[54]  Pillars article: fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient w/wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. , 2009, Journal of immunology.

[55]  H. Wekerle,et al.  Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions , 2009, Nature.

[56]  A. Volterra,et al.  Astrocytic dysfunction: Insights on the role in neurodegeneration , 2009, Brain Research Bulletin.

[57]  Michael Famulok,et al.  The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity , 2009, The Journal of experimental medicine.

[58]  S. Lehnardt,et al.  Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury , 2009, Glia.

[59]  V. Shestopalov,et al.  Inactivation of astroglial NF‐κB promotes survival of retinal neurons following ischemic injury , 2009, The European journal of neuroscience.

[60]  Andrés Hurtado,et al.  Transgenic inhibition of astroglial NF‐κB leads to increased axonal sparing and sprouting following spinal cord injury , 2009, Journal of neurochemistry.

[61]  M. Murakami,et al.  Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria , 2009, The Journal of experimental medicine.

[62]  P. Kubes,et al.  Bone Marrow-Derived Mast Cells Accumulate in the Central Nervous System During Inflammation but Are Dispensable for Experimental Autoimmune Encephalomyelitis Pathogenesis1 , 2009, The Journal of Immunology.

[63]  F. Gage,et al.  A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death , 2009, Cell.

[64]  R. Ransohoff,et al.  Localizing central nervous system immune surveillance: Meningeal antigen‐presenting cells activate T cells during experimental autoimmune encephalomyelitis , 2009, Annals of neurology.

[65]  Shizuo Akira,et al.  The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.

[66]  V. Perry,et al.  Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.

[67]  S. Barnum,et al.  Transgenic Inhibition of Astroglial NF-κB Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation1 , 2009, The Journal of Immunology.

[68]  U. Zettl,et al.  Animal models of multiple sclerosis for the development and validation of novel therapies – potential and limitations , 2008, Journal of Neurology.

[69]  Melissa A Brown,et al.  Mast Cells , 2008, Annals of the New York Academy of Sciences.

[70]  M. Kurrer,et al.  GM-CSF mediates autoimmunity by enhancing IL-6–dependent Th17 cell development and survival , 2008, The Journal of experimental medicine.

[71]  T. Jakob,et al.  Cutting Edge: Instructive Role of Peripheral Tissue Cells in the Imprinting of T Cell Homing Receptor Patterns1 , 2008, The Journal of Immunology.

[72]  T. Suuronen,et al.  Amyloid-β oligomers set fire to inflammasomes and induce Alzheimer's pathology , 2008, Journal of cellular and molecular medicine.

[73]  P. Halloran,et al.  The Puzzling Role of CXCR3 and Its Ligands in Organ Allograft Rejection , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[74]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[75]  T. Lane,et al.  The Th17–ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease , 2008, The Journal of experimental medicine.

[76]  V. Perry,et al.  Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration , 2008, Neurobiology of Disease.

[77]  B. Trapp,et al.  Preconditioning paradigms and pathways in the brain. , 2008, Cleveland Clinic journal of medicine.

[78]  F. Rossi,et al.  Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.

[79]  D. Cleveland,et al.  Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease , 2007, Nature Neuroscience.

[80]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[81]  F. Martinon,et al.  Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.

[82]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[83]  F. Martinon,et al.  NALP Inflammasomes: a central role in innate immunity , 2007, Seminars in Immunopathology.

[84]  G. Dubyak,et al.  Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1 , 2007, The Journal of Immunology.

[85]  Swati Banerjee,et al.  Neuron-glial interactions in blood-brain barrier formation. , 2007, Annual review of neuroscience.

[86]  Yan Ping Zhang,et al.  Transgenic glial nuclear factor-kappa B inhibition decreases formalin pain in mice , 2007, Neuroreport.

[87]  Colm Cunningham,et al.  The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) , 2007, Brain, Behavior, and Immunity.

[88]  S. Miller,et al.  Antigen Presentation in the CNS by Myeloid Dendritic Cells Drives Progression of Relapsing Experimental Autoimmune Encephalomyelitis , 2007, Annals of the New York Academy of Sciences.

[89]  P. Sansonetti,et al.  Sensing of bacteria: NOD a lonely job. , 2007, Current opinion in microbiology.

[90]  D. Bonifati,et al.  Role of complement in neurodegeneration and neuroinflammation. , 2007, Molecular immunology.

[91]  Colm Cunningham,et al.  Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.

[92]  M. Bianchi DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[93]  S. Hauser,et al.  The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration , 2006, Neuron.

[94]  W. Reith,et al.  TGFbeta receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis. , 2006, Brain : a journal of neurology.

[95]  Steffen Jung,et al.  Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.

[96]  S. Miller,et al.  CNS dendritic cells: Critical participants in CNS inflammation? , 2006, Neurochemistry International.

[97]  G. Kollias,et al.  Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.

[98]  S. Miller,et al.  Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease1 , 2006, The Journal of Immunology.

[99]  Carl Nathan,et al.  Neutrophils and immunity: challenges and opportunities , 2006, Nature Reviews Immunology.

[100]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[101]  V. Perry,et al.  Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.

[102]  C. Chen,et al.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.

[103]  E. J. Green,et al.  Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury , 2005, The Journal of experimental medicine.

[104]  P. Gasque,et al.  Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, “protective” glial stem cells and stromal ependymal cells , 2005, Brain Research Reviews.

[105]  E. Kremmer,et al.  Dendritic cells govern induction and reprogramming of polarized tissue‐selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments , 2005, European journal of immunology.

[106]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.

[107]  J. Mora,et al.  Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues , 2005, The Journal of experimental medicine.

[108]  L. O’Neill TLRs: Professor Mechnikov, sit on your hat. , 2004, Trends in immunology.

[109]  H. Thorlacius,et al.  Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids , 2004, Inflammation Research.

[110]  M. Minami,et al.  Endotoxin Preconditioning Prevents Cellular Inflammatory Response During Ischemic Neuroprotection in Mice , 2004, Stroke.

[111]  B. Rollins,et al.  Differential roles of CCL2 and CCR2 in host defense to coronavirus infection , 2004, Virology.

[112]  V. Perry The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease , 2004, Brain, Behavior, and Immunity.

[113]  Rongguo Yu,et al.  Activation of P2 nucleotide receptors stimulates acid efflux from astrocytes , 2004, Glia.

[114]  F. Martinon,et al.  Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.

[115]  B. Serafini,et al.  Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.

[116]  R. Fujinami,et al.  Distinct roles for IP-10/C XC L10 in three animal models, Theiler’s virus infection, EA E, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10 , 2004, Multiple sclerosis.

[117]  M. Kamoun,et al.  Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia , 2003, Journal of the Neurological Sciences.

[118]  C. Gutekunst,et al.  Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course 1 , 2003, The Journal of Immunology.

[119]  N. Gay,et al.  Binding of the Drosophila cytokine Spätzle to Toll is direct and establishes signaling , 2003, Nature Immunology.

[120]  C. Yiannoutsos,et al.  SDF‐1α Is Expressed in Astrocytes and Neurons in the AIDS Dementia Complex: An In Vivo and In Vitro Study , 2003 .

[121]  W. Kuziel,et al.  CC Chemokine Ligand 3 (CCL3) Regulates CD8+-T-Cell Effector Function and Migration following Viral Infection , 2003, Journal of Virology.

[122]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[123]  R. Dantzer,et al.  Interleukin-10 in the brain. , 2001, Critical reviews in immunology.

[124]  W. Kuziel,et al.  Lack of CCR2 Results in Increased Mortality and Impaired Leukocyte Activation and Trafficking Following Infection of the Central Nervous System with a Neurotropic Coronavirus1 , 2001, The Journal of Immunology.

[125]  Denise Feighan,et al.  P2X7-Like Receptor Activation in Astrocytes Increases Chemokine Monocyte Chemoattractant Protein-1 Expression via Mitogen-Activated Protein Kinase , 2001, The Journal of Neuroscience.

[126]  D. Remick,et al.  Early Chemokine Cascades in Murine Cardiac Grafts Regulate T Cell Recruitment and Progression of Acute Allograft Rejection1 , 2001, The Journal of Immunology.

[127]  G. Kollias,et al.  CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity , 2001, Nature Neuroscience.

[128]  M. Byrne,et al.  Microbial Lipopeptides Induce the Production of IL-17 in Th Cells1 , 2000, The Journal of Immunology.

[129]  V. Perry,et al.  Interleukin-1β-Induced Changes in Blood–Brain Barrier Permeability, Apparent Diffusion Coefficient, and Cerebral Blood Volume in the Rat Brain: A Magnetic Resonance Study , 2000, The Journal of Neuroscience.

[130]  M. Buchmeier,et al.  Cutting Edge: The T Cell Chemoattractant IFN-Inducible Protein 10 Is Essential in Host Defense Against Viral-Induced Neurologic Disease1 , 2000, The Journal of Immunology.

[131]  L. Weiner,et al.  Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor , 2000, Neurology.

[132]  C. Gutekunst,et al.  Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis , 2000, The Journal of experimental medicine.

[133]  S. McColl,et al.  Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.

[134]  Michael Schroeter,et al.  Inflammation and glial responses in ischemic brain lesions , 1998, Progress in Neurobiology.

[135]  J. Määttä,et al.  Neutrophils secreting tumor necrosis factor alpha infiltrate the central nervous system of BALB/c mice with experimental autoimmune encephalomyelitis , 1998, Journal of Neuroimmunology.

[136]  W. Streit,et al.  Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[137]  D. Irani Brain-derived gangliosides induce cell cycle arrest in a murine T cell line , 1998, Journal of Neuroimmunology.

[138]  E. Major,et al.  Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[139]  D. Griffin,et al.  Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. , 1996, Journal of immunology.

[140]  A. Reder,et al.  The mast cells of the multiple sclerosis brain , 1996, Journal of Neuroimmunology.

[141]  S. Majumder,et al.  Transcriptional regulation of chemokine gene expression in astrocytes , 1996, Journal of neuroscience research.

[142]  R. Ransohoff,et al.  Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. , 1996, Journal of immunology.

[143]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[144]  S. Hauser,et al.  Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients , 1995, Annals of neurology.

[145]  Roland Martin,et al.  Myelin basic protein‐specific T‐cell responses in identical twins discordant or concordant for multiple sclerosis , 1993, Annals of neurology.

[146]  R. Ransohoff,et al.  Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[147]  S. Galli,et al.  Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell- deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells , 1985, The Journal of experimental medicine.

[148]  L. Tuomisto,et al.  Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis , 1983, Agents and Actions.

[149]  D. J. Neumann Ueber das Vorkommen der sogenannten „Mastzellen” bei pathologischen Veränderungen des Gehirns , 1890, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[150]  B. Castellano,et al.  Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. , 2011, Frontiers in bioscience.

[151]  Ping Han 韩萍,et al.  Research progress on interleukin-33 and its roles in the central nervous system , 2011, Neuroscience Bulletin.

[152]  D. Hafler,et al.  T-cells in multiple sclerosis. , 2010, Results and problems in cell differentiation.

[153]  A. Planas,et al.  Astrocytes are very sensitive to develop innate immune responses to lipid‐carried short interfering RNA , 2009, Glia.

[154]  V. Perry,et al.  What is immune privilege (not)? , 2007, Trends in immunology.

[155]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.

[156]  A. Volterra,et al.  Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. , 2007, International review of neurobiology.

[157]  C. Yiannoutsos,et al.  SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. , 2003, Journal of neuropathology and experimental neurology.

[158]  I. Bechmann,et al.  Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. , 2003, Journal of neural transmission. Supplementum.

[159]  R. Hohlfeld,et al.  T-cell-mediated autoimmunity: novel techniques to characterize autoreactive T-cell receptors. , 2003, The American journal of pathology.

[160]  J. Tekstra,et al.  Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. , 1999, The American journal of pathology.

[161]  R. Ransohoff,et al.  Murine experimental autoimmune encephalomyelitis: a model of immune-mediated inflammation and multiple sclerosis. , 1997, Methods in enzymology.

[162]  R. Ransohoff,et al.  [13] Murine experimental autoimmune encephalomyelitis: A model of immune-mediated inflammation and multiple sclerosis , 1997 .